Next generation cancer models (non cmdc) molecular characterization and clinical data collection
Ended Awarded Last action
- Contract number
- 75N91020F00037
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $992,988
Award facts
- Contract value 100% obligated
- $992,988.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $992,988 |
About this award
This is a federal contract award from the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for the "NEXT GENERATION CANCER MODELS (NON CMDC) MOLECULAR CHARACTERIZATION AND CLINICAL DATA COLLECTION" project, with a ceiling value of $992,988.00. It is a cost-plus-fixed-fee delivery order contract with a period of performance ending on September 24, 2025. The contract is not set aside for any specific business category. Leidos Biomedical Research Inc. is an established Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing a wide range of biomedical research and facilities support services to federal agencies, with a focus on supporting programs at the National Institutes of Health (NIH).
Quick answers
Who was awarded contract 75N91020F00037?
75N91020F00037 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 25, 2020.
How much is contract 75N91020F00037 worth?
The government has obligated $992,988 on 75N91020F00037.
Is contract 75N91020F00037 an order under another contract?
Yes. 75N91020F00037 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00037 competed?
The extent of competition for 75N91020F00037 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award